Contact Us
General Inquiries
oppm@kumc.edu
913-588-2079
Funding
Stephanie Carani
scarani@kuendowment.org
913-588-5230
National Institutes of Health
Together, the NIH Therapeutics for Rare and Neglected Diseases (TRND) program and IAMI are demonstrating a new way for government and academia to work together for a positive effect on patients' lives.
The TRND program is an effort to encourage and speed the development of new drugs for rare and neglected diseases.
This program is specifically intended to stimulate drug discovery and development research collaborations between NIH and academic scientists, nonprofit organizations, and pharmaceutical and biotechnology companies working on rare and neglected illnesses.
IAMI's approach is extremely complementary to the objectives of the program.
About
The National Institutes of Health (NIH) is made up of 27 different components called Institutes and Centers. Each has its own specific research agenda. All but three of these components receive their funding directly from Congress and administrate their own budgets.
NIH's mission is to seek fundamental knowledge about the nature of behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability.
top